LumiThera's key innovation is a device for use by ophthalmologists that improves vision and slows its loss, with a focus on ...

An analysis of pivotal phase 3 trials shows supplements to arrest age-related macular degeneration have no effect on ...

The use of anticoagulants or antiplatelets was linked to a higher risk of intraocular hemorrhage requiring vitrectomy in ...

While pivotal research on therapies for neovascular age-related macular degeneration (nAMD) and geographic atrophy (GA) ...

Recently initiated Phase 1b/2 multiple ascending dose study intended to assess safety and preliminary efficacy in nAMD patients receiving up to ...

The FDA has granted Fast Track Designation to Sanofi’s SAR402663, an investigational one-time intravitreal gene therapy for ...

AgreementHorus Pharma becomes additional commercialization partner for Formycon's Eylea® biosimilar FYB203 in selected European countries under the brand name Baiama® 17.09.2025 / 06:30 CET/CESTThe ...

IRON MOUNTAIN — Garrett Eye Center in Iron Mountain is offering a new non-invasive treatment for early stage dry macular ...

Macular degeneration in younger people is rare, but it can affect people in their twenties. Juvenile macular degeneration is an inherited condition that affects central vision and can occur in ...

In celebration of Ophthalmology Times ' 50th anniversary, we asked leading experts in the field, in a perfect world, if they ...